The development of tamoxifen for breast cancer therapy: A tribute to the late Arthur L. Walpole V. Craig Jordan Review Pages: 197 - 209
Secreted growth factors from estrogen receptor-negative human breast cancer do not support growth of estrogen receptor-positive breast cancer in the nude mouse model C. Kent OsborneConnie R. RossLibbey J. Kitten Report Pages: 211 - 219
Cell cycle synchronization induced by tamoxifen and 17β-estradiol on MCF-7 cells using flow cytometry and a monoclonal antibody against bromodeoxyuridine S. BrunoA. Di VinciW. Giaretti Report Pages: 221 - 229
Role of polyamines in the growth of hormone-responsive experimental breast cancerin vivo Andrea ManniBetty BadgerS. Rafeeq Ahmed Report Pages: 231 - 240
Morphometric evaluation of microvessels surrounding hyperplastic and neoplastic mammary lesions Antonio OttinettiAnna Sapino Report Pages: 241 - 248
Tests for detecting recurrent disease in the follow-up of patients with breast cancer J. L. MansiH. M. EarlR. C. Coombes Report Pages: 249 - 254
Association of breast fluid coloration with age, ethnicity, and cigarette smoking Nicholas L. PetrakisRei MiikeBetty Chang-Lee Report Pages: 255 - 262
Breast cancer family history as a risk factor for early onset breast cancer Henry T. LynchPatrice WatsonJane Lynch Report Pages: 263 - 267
Cisplatin and 5-fluorouracil in refractory breast cancer patients: A phase II study Domenico AmorosoPaolo PronzatoRiccardo Rosso Brief communication Pages: 269 - 271
Markers in breast cancer: Does CEA add to the detection by CA 15.3? J. C. DelarueH. MouriesseF. May-Levin Brief communication Pages: 273 - 276